The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells

Translating the Histone Code

Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Axonal transection in the lesions of multiple sclerosis

Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029 · see citing works

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · see citing works

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · see citing works

Cannabinoid receptor localization in brain.

Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321 · see citing works

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196 · see citing works

The molecular logic of endocannabinoid signalling

Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · see citing works

Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations

Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,751 · see citing works

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585 · see citing works

Characterization of ameboid microglia isolated from developing mammalian brain

Giulian, D., & Baker, T. J. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02163.1986 · Cited by 1,300 · see citing works

Endocannabinoid Signaling in the Brain

Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260 · see citing works

CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity

Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208 · see citing works

Retrograde Inhibition of Presynaptic Calcium Influx by Endogenous Cannabinoids at Excitatory Synapses onto Purkinje Cells

Kreitzer, A. C., & Regehr, W. G. (2001) · Neuron · doi:10.1016/s0896-6273(01)00246-x · Cited by 873 · see citing works

Inflammation and glial responses in ischemic brain lesions

Stoll, G. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00034-3 · Cited by 794 · see citing works

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

Giuffrida, A., Parsons, L. H., Kerr, T. M., de Fonseca, F. R., Navarro, M. A., & Piomelli, D. (1999) · Nature Neuroscience · doi:10.1038/7268 · Cited by 771 · see citing works

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

Panikashvili, D., Simeonidou, C., Ben‐Shabat, S., Hanuš, L., Breuer, A., Mechoulam, R., & Shohami, E. (2001) · Nature · doi:10.1038/35097089 · Cited by 752 · see citing works

Cannabinoid-based drugs as anti-inflammatory therapeutics

Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728 · see citing works

Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

Galve‐Roperh, I., Sánchez, C., Cortés, M. L., del Pulgar, T. G., Izquierdo, M., & Guzmán, M. (2000) · Nature Medicine · doi:10.1038/73171 · Cited by 684 · see citing works

Modulation of transmitter release via presynaptic cannabinoid receptors

Schlicker, E., & Kathmann, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01805-8 · Cited by 671 · see citing works

Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration

Walter, L. M., Franklin, A. A., Witting, A., Wade, C. B., Xie, Y., Kunos, G., Mackie, K., & Stella, N. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01398.2003 · Cited by 666 · see citing works

New concepts in the immunopathogenesis of multiple sclerosis

Hemmer, B., Archelos, J., & Hartung, H. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn784 · Cited by 605 · see citing works

Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids

Alger, B. E. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00080-1 · Cited by 599 · see citing works

Serum‐free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus

Brewer, G. J. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490420510 · Cited by 546 · see citing works

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1

Bouaboula, M., Poinot‐Chazel, C., Bourrié, B., Canat, X., Calandra, B., Rinaldi, M. L., Fur, G. L., & Casellas, P. (1995) · Biochemical Journal · doi:10.1042/bj3120637 · Cited by 542 · see citing works

Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents

Llano, I., Leresche, N., & Marty, A. (1991) · Neuron · doi:10.1016/0896-6273(91)90059-9 · Cited by 494 · see citing works

Pain modulation by release of the endogenous cannabinoid anandamide

Walker, J. M., Huang, S. M., Strangman, N. M., Tsou, K., & Sañudo-Peña, M. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12198 · Cited by 486 · see citing works

An immortalized cell line expresses properties of activated microglial cells

Bocchini, V., Mazzolla, R., Barluzzi, R., Blasi, E., Sick, P., & Kettenmann, H. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310405 · Cited by 364 · see citing works

Cultured Rat Microglial Cells Synthesize the Endocannabinoid 2-Arachidonylglycerol, Which Increases Proliferation via a CB2 Receptor-Dependent Mechanism

Carrier, E. J., Kearn, C. S., Barkmeier, A. J., Breese, N. M., Yang, W., Nithipatikom, K., Pfister, S. L., Campbell, W. B., & Hillard, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.999 · Cited by 336 · see citing works

Functional CB1 cannabinoid receptors in human vascular endothelial cells

Liu, J., Gao, B., Mirshahi, F., Sanyal, A. J., Khanolkar, A. D., Makriyannis, A., & Kunos, G. (2000) · Biochemical Journal · doi:10.1042/bj3460835 · Cited by 335 · see citing works

Cannabinoids and neuroinflammation

Walter, L. M., & Stella, N. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705667 · Cited by 334 · see citing works

Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in Hippocampus

Derkinderen, P., Valjent, E., Toutant, M., Corvol, J., Enslen, H., Ledent, C. A., Trzăskos, J. M., Caboche, J., & Girault, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02371.2003 · Cited by 331 · see citing works

Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis

Arévalo‐Martín, Á., Vela, J. M., Molina‐Holgado, E., Borrell, J. I., & Guaza, C. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02511.2003 · Cited by 314 · see citing works

Behavioral Effects of Cannabinoid Agents in Animals

Chaperon, F., & Thiébot, M.-H. (1999) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v13.i3.20 · Cited by 311 · see citing works

Biosynthesis and inactivation of the endocannabinoid 2‐arachidonoylglycerol in circulating and tumoral macrophages

Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., Melck, D. J., Orlando, P., Wagner, J. A., & Kunos, G. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00631.x · Cited by 296 · see citing works

Signaling Pathway Associated with Stimulation of CB2 Peripheral Cannabinoid Receptor

Bouaboula, M., Poinot‐Chazel, C., Marchand, J., Canat, X., Bourrié, B., Rinaldi, M. L., Calandra, B., Fur, G. L., & Casellas, P. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0704p.x · Cited by 285 · see citing works

Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats

Mabuchi, T., Kitagawa, K., Ohtsuki, T., Kuwabara, K., Yagita, Y., Yanagihara, T., Hori, M., & Matsumoto, M. (2000) · Stroke · doi:10.1161/01.str.31.7.1735 · Cited by 280 · see citing works

Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide

Facchinetti, F., Giudice, E. D., Furegato, S., Passarotto, M., & Leon, A. (2002) · Glia · doi:10.1002/glia.10177 · Cited by 275 · see citing works

The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt

del Pulgar, T. G., Velasco, G., & Guzmán, M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470369 · Cited by 260 · see citing works

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid‐type CB2 receptor

Klegeris, A., Bissonnette, C. J., & McGeer, P. L. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705304 · Cited by 244 · see citing works

Lipopolysaccharide Induces Anandamide Synthesis in Macrophages via CD14/MAPK/Phosphoinositide 3-Kinase/NF-κB Independently of Platelet-activating Factor

Liu, J., Bátkai, S., Pacher, P., Harvey-White, J. D., Wagner, J. A., Cravatt, B. F., Gao, B., & Kunos, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306062200 · Cited by 234 · see citing works

Palmitoylethanolamide Increases after Focal Cerebral Ischemia and Potentiates Microglial Cell Motility

Franklin, A. A., Parmentier‐Batteur, S., Walter, L. M., Greenberg, D. A., & Stella, N. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07767.2003 · Cited by 230 · see citing works

The Central Cannabinoid Receptor (CB1) Mediates Inhibition of Nitric Oxide Production by Rat Microglial Cells

Waksman, Y., Olson, J. M., Carlisle, S. J., & Cabral, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38093-0 · Cited by 223 · see citing works

Control of the cell survival/death decision by cannabinoids

Guzmán, M., Sánchez, C., & Galve‐Roperh, I. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000177 · Cited by 223 · see citing works

Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegeneration

Hansen, H. H., Schmid, P. C., Bittigau, P., Lastres‐Becker, I., Berrendero, F., Manzanares, J., Ikonomidou, C., Schmid, H. H. O., Fernández‐Ruiz, J. J., & Hansen, H. S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00542.x · Cited by 215 · see citing works

Safety, tolerability, and efficacy of orally administered cannabinoids in MS

Killestein, J., Hoogervorst, E. L. J., Reif, M., Kalkers, N. F., Loenen, A. C. V., Staats, P. G. M., Gorter, R. W., Uitdehaag, B. M. J., & Polman, C. H. (2002) · Neurology · doi:10.1212/wnl.58.9.1404 · Cited by 209 · see citing works

The CB1 Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase

Rueda, D., Galve‐Roperh, I., Haro, A., & Guzmán, M. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.4.814 · Cited by 200 · see citing works

Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signalling

Piomelli, D., & Greengard, P. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90182-8 · Cited by 194 · see citing works

F‐ATPase: specific observation of the rotating c subunit oligomer of EFoEF1

Pänke, O., Gumbiowski, K., Junge, W., & Engelbrecht, S. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01436-8 · Cited by 189 · see citing works

P2X 7 receptors control 2-arachidonoylglycerol production by microglial cells

Witting, A., Walter, L. M., Wacker, J. L., Möller, T., & Stella, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306707101 · Cited by 187 · see citing works

Safety, tolerability, and efficacy of orally administered cannabinoids in MS

Russo, E. B. (2003) · Neurology · doi:10.1212/wnl.60.4.729-a · Cited by 184 · see citing works

Regulation of a Neuronal Form of Focal Adhesion Kinase by Anandamide

Derkinderen, P., Toutant, M., Burgaya, F., Bert, M. L., Siciliano, J. C., de Franciscis, V., Gelman, M., & Girault, J. (1996) · Science · doi:10.1126/science.273.5282.1719 · Cited by 180 · see citing works

Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1

Ullrich, O., Diestel, A., Eyüpoglu, I. Y., & Nitsch, R. (2001) · Nature Cell Biology · doi:10.1038/ncb1201-1035 · Cited by 175 · see citing works

Stimulation of Cannabinoid Receptor CB1 Induces krox-24 Expression in Human Astrocytoma Cells

Bouaboula, M., Bourrié, B., Rinaldi, M. L., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13973 · Cited by 175 · see citing works

Transcriptional Induction of MKP-1 in Response to Stress Is Associated with Histone H3 Phosphorylation-Acetylation

Li, J., Gorospe, M., Hutter, D., Barnes, J., Keyse, S. M., & Liu, Y. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.23.8213-8224.2001 · Cited by 173 · see citing works

The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide

Wartmann, M., Campbell, D., Subramanian, A., BURSTEIN, S. H., & Davis, R. J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00027-7 · Cited by 173 · see citing works

Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells

Berdyshev, E. V., Boichot, E., Germain, N., Allain, N., Anger, J.-P., & Lagente, V. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01007-8 · Cited by 167 · see citing works

2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-α production in murine macrophages, and in mice

Gallily, R., Breuer, A., & Mechoulam, R. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00653-1 · Cited by 163 · see citing works

Activation of Microglial Poly(ADP-Ribose)-Polymerase-1 by Cholesterol Breakdown Products during Neuroinflammation

Diestel, A., Aktas, O., Hackel, D., Häke, I., Meier, S., Raine, C. S., Nitsch, R., Zipp, F., & Ullrich, O. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030975 · Cited by 155 · see citing works

Anandamide induces apoptosis of PC‐12 cells: involvement of superoxide and caspase‐3

Sarker, K. P., Obara, S., Nakata, M., Kitajima, I., & Maruyama, I. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01425-3 · Cited by 151 · see citing works

A simple in vitro model of ischemia based on hippocampal slice cultures and propidium iodide fluorescence

Laake, J. H., Haug, F. Š., Wieloch, T. W., & Ottersen, O. P. (1999) · Brain Research Protocols · doi:10.1016/s1385-299x(99)00021-5 · Cited by 150 · see citing works

Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds

Howlett, A. C. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90278-9 · Cited by 150 · see citing works

Induction of tolerance in rat cortical neurons: hypoxic preconditioning

Bruer, U., Weih, M., Исаев, Н. К., Meisel, A., Ruscher, K., Bergk, A., Trendelenburg, G., Wiegand, F., Victorov, I. V., & Dirnagl, U. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00954-x · Cited by 131 · see citing works

Endocannabinoids accumulate in spinal cord of SOD1G93A transgenic mice

Witting, A., Weydt, P., Hong, S. Y., Kliot, M., Möller, T., & Stella, N. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02544.x · Cited by 112 · see citing works

Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors

Franklin, A., & Stella, N. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02074-0 · Cited by 111 · see citing works

Endocannabinoids Mediate Rapid Retrograde Signaling At Interneuron → Pyramidal Neuron Synapses of the Neocortex

Trettel, J., & Levine, E. S. (2003) · Journal of Neurophysiology · doi:10.1152/jn.01037.2002 · Cited by 109 · see citing works

Methods to induce primary and secondary traumatic damage in organotypic hippocampal slice cultures

Adamchik, Y., Frantseva, M. V., Weisspapir, M., Carlen, P. L., & Perez Velazquez, J. L. (2000) · Brain Research Protocols · doi:10.1016/s1385-299x(00)00007-6 · Cited by 101 · see citing works

Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability

Jacobsson, S. O. P., Rongård, E., Stridh, M., Tiger, G., & Fowler, C. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00492-5 · Cited by 94 · see citing works

Inhibition of the Expression of Mitogen-activated Protein Phosphatase-1 Potentiates Apoptosis Induced by Tumor Necrosis Factor-α in Rat Mesangial Cells

Guo, Y., Kang, B., & WILLIAMSON, J. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10362 · Cited by 83 · see citing works

Activated microglial cells migrate towards sites of excitotoxic neuronal injury inside organotypic hippocampal slice cultures

Heppner, F. L., Skutella, T., Hailer, N. P., Haas, D., & Nitsch, R. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00379.x · Cited by 78 · see citing works

Emerging properties of cannabinoid medicines in management of multiple sclerosis

Pryce, G., & Baker, D. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.03.006 · Cited by 76 · see citing works

Cannabinoids and neuroprotection in CNS inflammatory disease

Jackson, S. J., Diemel, L. T., Pryce, G., & Baker, D. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.002 · Cited by 70 · see citing works

Feedback Regulation of Raf-1 and Mitogen-activated Protein Kinase (MAP) Kinase Kinases 1 and 2 by MAP Kinase Phosphatase-1 (MKP-1)

Shapiro, P. S., & Ahn, N. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1788 · Cited by 68 · see citing works

Stout Guards of the Central Nervous System

Mechoulam, R., & Lichtman, A. H. (2003) · Science · doi:10.1126/science.1091256 · Cited by 67 · see citing works

Biosynthesis and turnover of anandamide and other N‐acylethanolamines in peritoneal macrophages

Kuwae, T., Shiota, Y., Schmid, P. C., Krebsbach, R. J., & Schmid, H. H. O. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01226-0 · Cited by 41 · see citing works

Cannabinoids in MS

Thompson, A. J., & Baker, D. (2002) · Neurology · doi:10.1212/wnl.58.9.1323 · Cited by 15 · see citing works

Physiology of Microglia

Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547 · see citing works

The Endocannabinoid System as an Emerging Target of Pharmacotherapy

Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077 · see citing works

Endocannabinoid-Mediated Control of Synaptic Transmission

Kano, M., Ohno‐Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529 · see citing works

Pathological and protective roles of glia in chronic pain

Milligan, E. D., & Watkins, L. R. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2533 · Cited by 1,404 · see citing works

MAPK phosphatases — regulating the immune response

Liu, Y., Shepherd, E. G., & Nelin, L. D. (2007) · Nature reviews. Immunology · doi:10.1038/nri2035 · Cited by 679 · see citing works

Neurotransmitter receptors on microglia

Pocock, J. M., & Kettenmann, H. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.07.007 · Cited by 650 · see citing works

The CB2 receptor and its role as a regulator of inflammation

Turcotte, C., Blanchet, M., Laviolette, M., & Flamand, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2300-4 · Cited by 598 · see citing works

Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomas

Stella, N. (2010) · Glia · doi:10.1002/glia.20983 · Cited by 529 · see citing works

From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology

Ligresti, A., PETROCELLIS, L. D., & Marzo, V. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 482 · see citing works

A biosynthetic pathway for anandamide

Liu, J., Wang, L., Harvey-White, J. D., Osei‐Hyiaman, D., Razdan, R. J., Gong, Q., Chan, A. C., Zhou, Z., Huang, B. X., Kim, H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601832103 · Cited by 468 · see citing works

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity

Palazuelos, J., Aguado, T., Pazos, M. R., Julien, B., Carrasco, C., Resel, E., Sagredo, O., Benito, C., Romero, J., Azcoitia, I., et al. (2009) · Brain · doi:10.1093/brain/awp239 · Cited by 382 · see citing works

Targeting p38 MAPK pathway for the treatment of Alzheimer's disease

Munoz, L., & Ammit, A. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.010 · Cited by 370 · see citing works

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

Fernández‐Ruíz, J., Romero, J., Velasco, G., Tolón, R. M., Ramos, J. A., & Guzmán, M. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.11.001 · Cited by 362 · see citing works

The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration

Ashton, J. C., & Glass, M. (2007) · Current Neuropharmacology · doi:10.2174/157015907780866884 · Cited by 336 · see citing works

DUSP Meet Immunology: Dual Specificity MAPK Phosphatases in Control of the Inflammatory Response

Lang, R., Hammer, M., & Mages, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7497 · Cited by 332 · see citing works

The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain

Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301 · see citing works

Cannabinoid CB 2 receptors in human brain inflammation

Benito, C., Tolón, R. M., Pazos, M. R., Núñez, E., Castillo, A. I., & Romero, J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707505 · Cited by 293 · see citing works

Endocannabinoid signaling in microglial cells

Stella, N. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.037 · Cited by 271 · see citing works

Regulation of MAP kinases by MAP kinase phosphatases

Kondoh, K., & Nishida, E. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.12.002 · Cited by 268 · see citing works

Cannabinoid CB₁and CB₂Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis

Benito, C., Romero, J. P., Tolón, R. M., Clemente, D., Docagne, F., Hillard, C. J., Guaza, C., & Romero, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4814-06.2007 · Cited by 256 · see citing works

Neuronal damage in brain inflammation

Aktas, O., Ullrich, O., Infante-Duarte, C., Nitsch, R., & Zipp, F. (2007) · Archives of Neurology · doi:10.1001/archneur.64.2.185 · Cited by 249 · see citing works

Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites

Turcotte, C., Chouinard, F., Lefebvre, J. S., & Flamand, N. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0115-021r · Cited by 249 · see citing works

Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation

Rom, S., & Persidsky, Y. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9445-9 · Cited by 240 · see citing works

WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease

Price, D. A., Martinez, A. A., Seillier, A., Koek, W., Acosta, Y. P. V., Fernández, E., Strong, R., Lutz, B., Marsicano, G., Roberts, J. L., et al. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06764.x · Cited by 231 · see citing works

Endocannabinoids and immune regulation☆

Pandey, R., Mousawy, K. M., Nagarkatti, M., & Nagarkatti, P. S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.03.019 · Cited by 232 · see citing works

Endocannabinoids drive the acquisition of an alternative phenotype in microglia

Mecha, M., Feliú, A., Carrillo-Salinas, F. J., Rueda-Zubiaurre, A., Ortega-Gutiérrez, S., de Sola, R. G., & Guaza, C. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.002 · Cited by 234 · see citing works

Non‐psychoactive CB 2 cannabinoid agonists stimulate neural progenitor proliferation

Palazuelos, J., Aguado, T., Egia, A., Mechoulam, R., Guzmán, M., & Galve‐Roperh, I. (2006) · The FASEB Journal · doi:10.1096/fj.06-6164fje · Cited by 222 · see citing works

An overview of the cannabinoid type 2 receptor system and its therapeutic potential

Bie, B., Wu, J., Foss, J. F., & Naguib, M. (2018) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000616 · Cited by 208 · see citing works

The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis

Centonze, D., Bari, M., Rossi, S., Prosperetti, C., Furlan, R., Fezza, F., De Chiara, V., Battistini, L., Bernardi, G., Bernardini, S., et al. (2007) · Brain · doi:10.1093/brain/awm160 · Cited by 207 · see citing works

Cyclooxygenase-2 in synaptic signaling

Yang, H., & Chen, C. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480144 · Cited by 195 · see citing works

Crucial Role of CB₂Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain

Racz, I., Nadal, X., Alferink, J., Baños, J. E., Rehnelt, J., Martín, M., Pintado, B., Gutierrez-Adan, A., Sanguino, E., Manzanares, J., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3400-08.2008 · Cited by 195 · see citing works

Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection

Rosenberg, E. C., Patra, P. H., & Whalley, B. J. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.11.006 · Cited by 193 · see citing works

Microglia in central nervous system repair after injury

Jin, X., & Yamashita, T. (2016) · The Journal of Biochemistry · doi:10.1093/jb/mvw009 · Cited by 191 · see citing works

Therapeutic approaches to inflammation in neurodegenerative disease

Klegeris, A., McGeer, E. G., & McGeer, P. L. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3280adc943 · Cited by 186 · see citing works

Anandamide enhances IL‐10 production in activated microglia by targeting CB2receptors: Roles of ERK1/2, JNK, and NF‐κB

Correa, F., Hernangómez, M., Mestre, L., Loría, F., Spagnolo, A., Docagne, F., Marzo, V. D., & Guaza, C. (2009) · Glia · doi:10.1002/glia.20907 · Cited by 183 · see citing works

The endocannabinoid system in targeting inflammatory neurodegenerative diseases

Centonze, D., Finazzi‐Agrò, A., Bernardi, G., & Maccarrone, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.004 · Cited by 180 · see citing works

The endocannabinoid system as a target for the treatment of neurodegenerative disease

Scotter, E. L., Abood, M. E., & Glass, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00735.x · Cited by 181 · see citing works

Anti-inflammatory lipoxin A 4 is an endogenous allosteric enhancer of CB 1 cannabinoid receptor

Pamplona, F. A., Ferreira, J., de Lima, O. M., Duarte, F. S., Bento, A. F., Forner, S., Villarinho, J. G., Bellocchio, L., Wotjak, C. T., Lerner, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202906109 · Cited by 178 · see citing works

Glucocorticoids exacerbate lipopolysaccharide-induced signaling in the frontal cortex and hippocampus in a dose-dependent manner

Munhoz, C. D., Sorrells, S. F., Caso, J. R., Scavone, C., & Sapolsky, R. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0303-09.2010 · Cited by 169 · see citing works

Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury

Romero-Sandoval, A., Nutile-McMenemy, N., & DeLeo, J. A. (2008) · Anesthesiology · doi:10.1097/aln.0b013e318167af74 · Cited by 168 · see citing works

The CB2 Cannabinoid Receptor Controls Myeloid Progenitor Trafficking

Palazuelos, J., Davoust, N., Julien, B., Hatterer, E., Aguado, T., Mechoulam, R., Benito, C., Romero, J., Silva, A., Guzmán, M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707960200 · Cited by 168 · see citing works

Cannabinoid Receptors and Endocannabinoids: Role in Neuroinflammatory and Neurodegenerative Disorders

Bisogno, T., & Marzo, V. D. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710793361568 · Cited by 159 · see citing works

CANnabinoid Receptor Type 2 Activation Induces a Microglial Anti-Inflammatory Phenotype and Reduces Migration via MKP Induction and ERK Dephosphorylation

Romero-Sandoval, E. A., Horvath, R. J., Landry, R. P., & DeLeo, J. A. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-25 · Cited by 159 · see citing works

Microglia activation states and cannabinoid system: Therapeutic implications

Mecha, M., Carrillo-Salinas, F. J., Feliú, A., Mestre, L., & Guaza, C. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.011 · Cited by 160 · see citing works

Role of TGFβ signaling in the pathogenesis of Alzheimer’s disease

von Bernhardi, R., Cornejo, F., Parada, G. E., & Eugenín, J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00426 · Cited by 149 · see citing works

Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment

Murikinati, S. R., Jüttler, E., Keinert, T., Ridder, D. A., Muhammad, S., Waibler, Z., Ledent, C. A., Zimmer, A., Kalinke, U., & Schwaninger, M. (2009) · The FASEB Journal · doi:10.1096/fj.09-141275 · Cited by 157 · see citing works

The endocannabinoid system in normal and pathological brain ageing

Bilkei‐Gorzó, A. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0388 · Cited by 157 · see citing works

Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations

Tronel, C., Largeau, B., Ribeiro, M. J., Guilloteau, D., Dupont, A.-C., & Arlicot, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040802 · Cited by 154 · see citing works

Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation

Kaminska, B., Mota, M., & Pizzi, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.026 · Cited by 153 · see citing works

Epigenetics Control Microglia Plasticity

Cheray, M., & Joseph, B. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00243 · Cited by 151 · see citing works

Anti-inflammatory mechanism of ginseng saponins in activated microglia

Park, J., Park, E., Kim, D., Jung, K., Jung, J.-S., Lee, E.-J., Hyun, J., Kang, J. L., & Kim, H.-S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.01.020 · Cited by 143 · see citing works

Neuroimmune interactions and pain: focus on glial-modulating targets.

Romero-Sandoval, E. A., Horvath, R. J., & DeLeo, J. A. (2008) · PubMed · Cited by 140 · see citing works

The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases

Chiurchiù, V., van der Stelt, M., Centonze, D., & Maccarrone, M. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.007 · Cited by 140 · see citing works

Cannabinoids and autoimmune diseases: A systematic review

Katchan, V., David, P., & Shoenfeld, Y. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.008 · Cited by 143 · see citing works

Endocannabinoids in Synaptic Plasticity and Neuroprotection

Xu, J., & Chen, C. (2014) · The Neuroscientist · doi:10.1177/1073858414524632 · Cited by 138 · see citing works

Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease

Wancket, L. M., Frazier, W. J., & Liu, Y. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.11.017 · Cited by 134 · see citing works

Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation

Zhang, J., & Chen, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800524200 · Cited by 135 · see citing works

Inhibition of COX‐2 expression by endocannabinoid 2‐arachidonoylglycerol is mediated via PPAR‐γ

Du, H., Chen, X., Zhang, J., & Chen, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01444.x · Cited by 133 · see citing works

Interferon-γ Is a Critical Modulator of CB2Cannabinoid Receptor Signaling during Neuropathic Pain

Rácz, I., Nadal, X., Alferink, J., Baños, J.-E., Rehnelt, J., Martín, M., Pintado, B., Gutiérrez‐Adán, A., Sanguino, E., Bellora, N., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3402-08.2008 · Cited by 134 · see citing works

G protein‐coupled receptor 84, a microglia‐associated protein expressed in neuroinflammatory conditions

Bouchard, C., Pagé, J., Bédard, A., Tremblay, P., & Vallières, L. (2007) · Glia · doi:10.1002/glia.20506 · Cited by 132 · see citing works

Oxidation of the Endogenous Cannabinoid Arachidonoyl Ethanolamide by the Cytochrome P450 Monooxygenases: Physiological and Pharmacological Implications

Snider, N. T., Walker, V. J., & Hollenberg, P. F. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.001081 · Cited by 132 · see citing works

CD200‐CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation

Hernangómez, M., Mestre, L., Correa, F., Loría, F., Mecha, M., Iñigo, P. M., Docagne, F., Williams, R. O., Borrell, J. I., & Guaza, C. (2012) · Glia · doi:10.1002/glia.22366 · Cited by 130 · see citing works

The Endocannabinoid System and Neurogenesis in Health and Disease

Galve‐Roperh, I., Aguado, T., Palazuelos, J., & Guzmán, M. (2007) · The Neuroscientist · doi:10.1177/1073858406296407 · Cited by 129 · see citing works

The endocannabinoid system is modulated in response to spinal cord injury in rats

García‐Ovejero, D., Arévalo‐Martín, Á., Petrosino, S., Docagne, F., Hagen, C., Bisogno, T., Watanabe, M., Guaza, C., Marzo, V. D., & Molina‐Holgado, E. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.09.015 · Cited by 125 · see citing works

Role of CB2 receptors in neuroprotective effects of cannabinoids

Fernández‐Ruíz, J., Pazos, M. R., Garcı́a-Arencibia, M., Sagredo, O., & Ramos, J. A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.001 · Cited by 125 · see citing works

Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults

Chen, X., Zhang, J., & Chen, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.01.024 · Cited by 123 · see citing works

Effects of pro‐inflammatory cytokines on cannabinoid CB 1 and CB 2 receptors in immune cells

Jean-Gilles, L., Braitch, M. K., Latif, M. L., Aram, J., Fahey, A. J., Edwards, L. J., Robins, R. A., Tănăsescu, R., Tighe, P. J., Gran, B., et al. (2015) · Acta Physiologica · doi:10.1111/apha.12474 · Cited by 123 · see citing works

Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation

Pálóczi, J., Varga, Z. V., Hasko, G., & Pacher, P. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7144 · Cited by 121 · see citing works

Mechanisms of Control of Neuron Survival by the Endocannabinoid System

Galve‐Roperh, I., Aguado, T., Palazuelos, J., & Guzmán, M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740117 · Cited by 121 · see citing works

Neuroprotective agents: Cannabinoids

Sánchez, A., & Garcı́a-Merino, A. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.02.010 · Cited by 119 · see citing works

MicroRNA: Small RNA mediators of the brains genomic response to environmental stress

Hollins, S. L., & Cairns, M. J. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.005 · Cited by 117 · see citing works

Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells

Juknat, A., Pietr, M., Kozela, E., Rimmerman, N., Levy, R., Gao, F., Coppola, G., Geschwind, D. H., & Vogel, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061462 · Cited by 117 · see citing works

MAP Kinase Phosphatase 1 (MKP-1/DUSP1) Is Neuroprotective in Huntington's Disease via Additive Effects of JNK and p38 Inhibition

Taylor, D. M., Moser, R., Régulier, E., Breuillaud, L., Dixon, M. A., Beesen, A. A., Elliston, L., Santos, M. D. F. S., Kim, J., Jones, L., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4965-11.2013 · Cited by 116 · see citing works

Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures

Małek, N., Popiołek-Barczyk, K., Mika, J., Przewłocka, B., & Starowicz, K. (2015) · Neural Plasticity · doi:10.1155/2015/130639 · Cited by 114 · see citing works

Dexamethasone suppresses monocyte chemoattractant protein‐1 production via mitogen activated protein kinase phosphatase‐1 dependent inhibition of Jun N‐terminal kinase and p38 mitogen‐activated protein kinase in activated rat microglia

Zhou, Y., Ling, E., & Dheen, S. T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04535.x · Cited by 115 · see citing works

Cannabinoids and Multiple Sclerosis

Pertwee, R. G. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0005-2 · Cited by 113 · see citing works

Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease

Concannon, R. M., Okine, B. N., Finn, D. P., & Dowd, E. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.04.007 · Cited by 112 · see citing works

Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia

Huo, Y., Rangarajan, P., Ling, E., & Dheen, S. T. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-49 · Cited by 112 · see citing works

Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2Receptor Agonists

Tabrizi, M. A., Baraldi, P. G., Borea, P. A., & Varani, K. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00411 · Cited by 110 · see citing works

The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders

Galve‐Roperh, I., Palazuelos, J., Aguado, T., & Guzmán, M. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0028-y · Cited by 110 · see citing works

Cannabinoids and the Brain

Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 110 · see citing works

The endocannabinoid pathway in Huntington's disease: A comparison with other neurodegenerative diseases

Maccarrone, M., Battista, N., & Centonze, D. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.006 · Cited by 106 · see citing works

HIV-1 infection and alcohol abuse: Neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions

Persidsky, Y., Ho, W., Ramirez, S. H., Potula, R., Abood, M. E., Unterwald, E. M., & Tuma, R. F. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.001 · Cited by 106 · see citing works

The role of endocannabinoids in pain modulation

Zogopoulos, P., Vasileiou, I., Patsouris, E., & Theocharis, S. E. (2013) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12008 · Cited by 106 · see citing works

Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis

Marchalant, Y., Brothers, H. M., Norman, G. J., Karelina, K., DeVries, A. C., & Wenk, G. L. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.014 · Cited by 103 · see citing works

Modulating the delicate glial–neuronal interactions in neuropathic pain: Promises and potential caveats

Tiwari, V., Guan, Y., & Raja, S. N. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.05.002 · Cited by 103 · see citing works

Microglial Activation in Alzheimers Disease

Schlachetzki, J. C. M., & Hüll, M. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147179 · Cited by 102 · see citing works

Cannabinoid signaling in health and disease

Lu, Y., & Anderson, H. D. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0346 · Cited by 102 · see citing works

Endocannabinoids in immune regulation and immunopathologies

Rahaman, O., & Ganguly, D. (2021) · Immunology · doi:10.1111/imm.13378 · Cited by 102 · see citing works

Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke

Zhang, M., Martin, B. R., Adler, M. W., Razdan, R. J., Kong, W., Ganea, D., & Tuma, R. F. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9148-4 · Cited by 101 · see citing works

Plasma endocannabinoid levels in multiple sclerosis

Jean-Gilles, L., Feng, S., Tench, C. R., Chapman, V., Kendall, D. A., Barrett, D. A., & Constantinescu, C. S. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.07.021 · Cited by 100 · see citing works

Intrathecal cannabilactone CB2R agonist, AM1710, controls pathological pain and restores basal cytokine levels

Wilkerson, J. L., Gentry, K. R., Dengler, E. C., Wallace, J. A., Kerwin, A. A., Armijo, L. M., Kuhn, M. N., Thakur, G. A., Makriyannis, A., & Milligan, E. D. (2012) · Pain · doi:10.1016/j.pain.2012.02.015 · Cited by 99 · see citing works

A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells

Correa, F., Docagne, F., Mestre, L., Clemente, D., Hernangómez, M., Loría, F., & Guaza, C. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.014 · Cited by 98 · see citing works

The cannabinoid system and microglia in health and disease

Duffy, S. S., Hayes, J. P., Fiore, N. T., & Moalem‐Taylor, G. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108555 · Cited by 96 · see citing works

Detrimental effects of arachidonic acid and its metabolites in cellular and mouse models of Alzheimer's disease: structural insight

Amtul, Z., Uhrig, M., Wang, L., Rozmahel, R. F., & Beyreuther, K. T. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.07.014 · Cited by 96 · see citing works

Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner

Lowin, T., Apitz, M., Anders, S., & Straub, R. H. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0845-5 · Cited by 94 · see citing works

Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: A non-genomic anti-inflammatory switch

Malcher‐Lopes, R., Franco, A. J., & Tasker, J. G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.033 · Cited by 92 · see citing works

COX‐2 oxidative metabolite of endocannabinoid 2‐AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity

Sang, N., Zhang, J., & Chen, C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04668.x · Cited by 91 · see citing works

The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation

Young, A. P., & Denovan‐Wright, E. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.806417 · Cited by 90 · see citing works

Modulation of the endocannabinoid system: Neuroprotection or neurotoxicity?

Fowler, C. J., Rojo, M. L., & Rodríguez‐Gaztelumendi, A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.021 · Cited by 88 · see citing works

Cannabinoids in Microglia: A New Trick for Immune Surveillance and Neuroprotection

Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2005.12.004 · Cited by 26 · see citing works

Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies

Vázquez, C., Tolón, R. M., Pazos, M. R., Moreno, M., Koester, E. C., Cravatt, B. F., Hillard, C. J., & Romero, J. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.005 · Cited by 42 · see citing works

CD200‐CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation

Hernangómez, M., Mestre, L., Correa, F., Loría, F., Mecha, M., Iñigo, P. M., Docagne, F., Williams, R. O., Borrell, J. I., & Guaza, C. (2012) · Glia · doi:10.1002/glia.22366 · Cited by 130 · see citing works

Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by the excess microglia-mediated inflammation.

Guo, S., Liu, Y., Ma, R., Li, J., & Su, B. (2016) · Europe PMC (PubMed Central) · Cited by 11 · see citing works

P.3.f.002 CNS infections during childhood and risk for schizophrenia: a case control study

Halperin, D. S., Davidson, M., Werbeloff, N., Yoffe, R., Levine, A., Livni, G., & Weiser, M. (2008) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(08)70707-7